drugset / Trial / NCT00497952
Allogeneic Stem Cell Transplantation for the Treatment of Multiple Sclerosis
NaSingle-groupOpen-labelTreatment
Summary
The goal of this research study is to establish chimerism with the goal to halt disease progression in patients with Multiple Sclerosis.
Timeline
- Start
- 2007-07
- Primary completion
- 2024-12
- Completion
- 2024-12
Outcome
Outcome not reported
Stopped: “all clinical development programs terminated by sponsor”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | hematopoetic stem cell infusion | Cell therapy | — | — |